GAPDH and cancer: Since the Warburg effect can support aggressiveness and drug resistance of cancer cells [22], we further investigated whether the GAPDH inhibitor AXP-3019 may determine antiproliferative synergism with gemcitabine (GEM), an inhibitor of DNA polymerization used as standard treatment in PDAC patients.